Skip to main content
DrugPrice

Orencia

Abatacept

Generic availableAutoimmune Diseasesby Bristol-Myers Squibb
$3,546.00
avg cost per claim
-4.2% year-over-year
$1.2B
Medicare Spending
348,000
Total Claims
42,000
Beneficiaries
$29,381.00
Annual Cost/Patient

Why Orencia Costs $3,546.00 Per Claim

Orencia (Abatacept) is used to treat autoimmune diseases. According to CMS Medicare Part D spending data, the program spent $1.2B on this drug, covering 42,000 beneficiaries across 348,000 claims.

A generic version of this drug is available, which means lower-cost alternatives exist. Patients should ask their pharmacist about generic Abatacept or talk to their doctor about therapeutic alternatives that may cost less.

Price Breakdown

Avg cost per claim (30-day)$3,546.00
Avg annual cost per patient$29,381.00
Total Medicare spending$1.2B
Total claims348,000
Beneficiaries42,000

Drug Details

Brand Name
Orencia
Generic Name
Abatacept
Active Ingredient
Abatacept
Manufacturer
Bristol-Myers Squibb
Dosage Form
N/A
Route
N/A
Condition
Autoimmune Diseases
FDA Application
BLA125057

Frequently Asked Questions

Orencia (Abatacept) costs an average of $3,546.00 per claim based on Medicare Part D data. The estimated annual cost per patient is $29,381.00. Actual out-of-pocket costs depend on your insurance plan and pharmacy.

Yes, a generic version of Orencia (Abatacept) is available. Generic medications typically cost 80-95% less than brand-name drugs. Ask your pharmacist about generic Abatacept.

Medicare Part D spent $1.2B on Orencia, covering 42,000 beneficiaries across 348,000 claims. This makes it one of the tracked drugs in the Medicare spending dashboard.

Ask your pharmacist about generic Abatacept, which is typically much cheaper. You can also compare prices at different pharmacies, use prescription discount programs, or ask your doctor about therapeutic alternatives in the same drug class.

Cost data reflects Medicare Part D spending and may not represent retail pharmacy prices. Average cost per claim represents the total drug cost (not patient out-of-pocket) divided by total claims.